Menu
Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 3
Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes
Authors Roussakis, Piccini P, Politis M
Received 21 January 2013
Accepted for publication 3 April 2013
Published 28 June 2013 Volume 2013:3 Pages 33—39
DOI https://doi.org/10.2147/DNND.S19807
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Andreas-Antonios Roussakis, Paola Piccini, Marios Politis
Centre for Neuroinflammation and Neurodegeneration, Imperial College London, London, United Kingdom
Abstract: The diagnosis of movement disorders including Parkinsonian syndromes and essential tremor is mainly clinical. The most common diagnostic errors for Parkinson's disease include misdiagnoses such as Parkinson plus syndromes and cases of essential tremor. In this article, we discuss the clinical utility of DaTscan™ (123I-Ioflupane injection) and its diagnostic value in Parkinson's disease and the other Parkinsonian syndromes. Single photon emission computed tomography with 123I-Ioflupane can be useful to assist in the diagnosis of uncertain cases of Parkinsonism. An accurate diagnosis can aid clinicians in making correct decisions that are related to the overall management and treatment of Parkinson's disease, avoiding common therapeutic errors.
Keywords: DaTscan, SPECT, 123I-Ioflupane, 123I-β-FP-CIT, Parkinsonism
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.